Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pai-Neng-Da Capsule plus R-CHOP-21 in B-cell non-Hodgkin's lymphoma
ChiCTR2200055579Phase 3Completed
- Sponsor
- Lishui City Central Hospital
- Start
- Jun 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of pai-neng-da in B-cell non-Hodgkin lymphoma (B-NHL) (2 arms), sponsored by Lishui City Central Hospital. Primary endpoints: Peripheral blood cell count and T cell subsets. Started Jun 2015; status: completed.
02
Drugs
pai-neng-da
03
Conditions
B-cell non-Hodgkin lymphoma (B-NHL)
Beyond the preview
Go deeper on ChiCTR2200055579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055579.